AggreGuide 325 mg. Aspirin Study for Aspirin Induced Platelet Dysfunction

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01915407

Enrollment

150

Registered

2013-08-02

Start date

2013-04-30

Completion date

2013-07-31

Last updated

2013-08-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Platelet Dysfunction Due to Aspirin Ingestion

Brief summary

To test the AggreGuide A-100 AA Assay's effectiveness for detecting aspirin induced platelet dysfunction.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* over 18

Exclusion criteria

* on aspirin in prior week * medical history of platelet disorders * contraindications to aspirin

Design outcomes

Primary

Measure	Time frame	Description
Platelet Activity Index (PAI) before and after ingestion of aspirin	2 - 30 hours post aspirin ingestion	PAI is the proprietary reporting unit of the Aggreguide. It is related to the amount of platelet aggregation in the sample of whole blood.

Countries

United States

Outcome results